4.7 Letter

Rinnonabant as an adjunct therapy in overweight/obese patients with type 2 diabetes: reply

Journal

EUROPEAN HEART JOURNAL
Volume 28, Issue 11, Pages 1402-1402

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/eurheartj/ehm124

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available